Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Operating Income: 2009-2024

Historic Operating Income for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -$6.4 million.

  • Cumberland Pharmaceuticals' Operating Income fell 15.98% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 69.70%. This contributed to the annual value of -$6.4 million for FY2024, which is 32.68% up from last year.
  • Cumberland Pharmaceuticals' Operating Income amounted to -$6.4 million in FY2024, which was up 32.68% from -$9.6 million recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Operating Income ranged from a high of -$5.7 million in FY2022 and a low of -$9.6 million during FY2023.
  • Its 3-year average for Operating Income is -$7.2 million, with a median of -$6.4 million in 2024.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Operating Income tumbled by 67.48% in 2023, and later skyrocketed by 32.68% in 2024.
  • Cumberland Pharmaceuticals' Operating Income (Yearly) stood at -$6.4 million in 2020, then fell by 20.31% to -$7.7 million in 2021, then rose by 25.69% to -$5.7 million in 2022, then crashed by 67.48% to -$9.6 million in 2023, then soared by 32.68% to -$6.4 million in 2024.